CYCN

Cyclerion Therapeutics, Inc.

Contracts

Total Value

Stock Metrics

1.3%

Short % Float

2.6d to cover · Low squeeze

70.9%

Inst % Float

10 holders · 2026-06-30

Kalehua Capital Ma

Top Holder

35.3% of float

3.6M sh

Public Float

54/100

Dilution Score

High

3 mo

Cash Runway

Verified regulatory filings & proprietary analysis.

Dilution Risk

54/100

HIGH

Inst: 70.86% · Top: Kalehua Capital Management LLC

Biotech Analytics

Biotech / Pharma

9.94

Dilution Risk: HIGHBiotech Grade: F

Insider Buying0

Publications100

Dilution Risk54

Clinical Trials0

Short Interest10